Nicotine-containing pharmaceutical composition
US11129898B2 · kind B2 · utility
1Cited by
91References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 2014 |
| Grant date | Sep 28, 2021 |
| Priority date | — |
| Expiry date | Mar 30, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition intended to be employed for therapeutic purposes incorporates a nicotinic compound, a sugar substitute, and a sugar alcohol syrup. Representative forms of nicotine include free base (e.g., as a mixture of nicotine and microcrystalline cellulose), a nicotine salt (e.g., as nicotine bitartrate) or nicotine polacrilex. The composition is useful for treatment of central nervous system conditions, diseases, and disorders, and as a nicotine replacement therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.